IDH2 and myelodysplastic syndrome: Mutations in IDH1 and IDH2 are relatively rare in MDS patients, however they have been associated with unfavorable disease progression (20). IDH2 mutations are found in 2.1%–4.0% of cases, while IDH1 mutations occur in 0.6%–3.6% of patients (7).